Mkts

Rani Therapeutics Holdings, Inc.

NASDAQ: RANI
$0.61-0.01 (-1.61%)
As of Oct 29, 4:00 PM ET

Key statistics

Day range
0.600.61
52-week range
0.572.63
Today
Open0.61
Previous close0.61
Volume—
Valuation
Market cap84.39M
P/E ratio—
EPS (TTM)-0.26
Income & risk
Dividend / yield—
Beta0.70
Avg volume700.7K
Discussion

RANI News

Stories mentioning RANI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,7081,4610.000.00172.001,0280.000.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development5,1614,9093,2215,5056,5706,8096,1726,115
Sales General & Admin
Total Operating Expenses10,0479,9967,25710,50512,18515,98511,79912,524
Operating Income (Loss)(8,339)(8,535)(7,257)(10,505)(12,013)(14,957)(11,799)(12,524)
Interest Income
Interest Expense88.00346.00725.00877.00943.001,1261,3371,276
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(7,033)(10,305)(5,412)(6,692)(7,264)(8,947)(6,783)(6,805)
Earnings Per Share (Basic)(0.04)(156.14)(0.12)(0.18)(0.22)(319.54)(0.24)(0.26)
Earnings Per Share (Diluted)(0.04)(156.14)(0.12)(0.18)(0.22)(319.54)(0.24)(0.26)
Weighted Average Shares Outstanding (Basic)179,99666.0046,44436,54233,44028.0028,83626,324
Weighted Average Shares Outstanding (Diluted)179,99666.0046,44436,54233,44028.0028,83626,324

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RANI

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) is a stock listed on the Nasdaq Stock Market under the ticker symbol RANI. It last traded at $0.6100 (Oct 29, 2026, 4:00 PM ET), down 1.6% on the day. That gives Rani Therapeutics a market capitalisation of $84.4M.

Over the past 52 weeks RANI has traded between $0.5700 and $2.63.

Revenue for the quarter ended Mar 31, 2026 was $1.7M; a net loss of $7.0M. Revenue was up 893% from $172.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$1.7M-$7.0M-411.8%
Dec 31, 2025$1.5M-$10.3M-705.3%
Sep 30, 2025$0-$5.4M—
Jun 30, 2025$0-$6.7M—

From Rani Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…